SCHEMBL23967443

SCHEMBL23967443

O=C1c2ccccc2C(=O)N1C1CCCCCCC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.65
HPGD P15428 4/20 0.55
HSD17B10 Q99714 3/20 0.55
MAPT P10636 2/20 0.55
PKM P14618 1/20 0.55
ALOX15 P16050 1/20 0.55
ALOX12 P18054 1/20 0.55
MC4R P32245 1/20 0.55
NPSR1 Q6W5P4 2/20 0.53
KDM4E B2RXH2 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ATM Q13315 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.50
MAPK1 P28482 2/20 0.49
CYP2C19 P33261 2/20 0.49
TSHR P16473 3/20 0.47
CYP1A2 P05177 2/20 0.47
CHRM2 P08172 1/20 0.47
OPRM1 P35372 1/20 0.47
DDB1 Q16531 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30987468 1.00 ALDH1A1 (0.65) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL2653818 1.00 ALDH1A1 (0.65) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL18935574 0.98 ALDH1A1 (0.62) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL7201032 0.94 ALDH1A1 (0.57) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL30212234 0.94 ALDH1A1 (0.57) ALDH1A1HPGDHSD17B10MAPTPKM
Bicarbonate SCHEMBL14811674 0.93 ALDH1A1 (0.58) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL2665681 0.89 L3MBTL1 (0.54) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL9625796 0.89 L3MBTL1 (0.54) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL109413 0.87 ALDH1A1 (0.53) ALDH1A1HPGDHSD17B10MAPTPKM
SCHEMBL29600139 0.87 ALDH1A1 (0.53) ALDH1A1HPGDHSD17B10MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3481826-B1 TYROSINE KINASE INHIBITORS RIGEL PHARMACEUTICALS INC (US) 2021-11-03 EP disclosed